(Q45232711)

11 December 2017

title

Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods (English)

1 reference

11 December 2017

1 reference

J C Morris

1

1 reference

11 December 2017

I D Hay

series ordinal

2

1 reference

11 December 2017

R E Nelson

series ordinal

3

1 reference

11 December 2017

N S Jiang

series ordinal

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

11 December 2017

1 reference

11 December 2017

volume

63

1 reference

11 December 2017

issue

7

1 reference

11 December 2017

page(s)

707-717

1 reference

Culture of hormone-dependent functional epithelial cells from rat thyroids

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Graves’ IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Comparative evaluation of cyclic AMP and iodide accumulation responses to thyroid-stimulating immunoglobulins in cultured FRTL-5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Characterization of the Optimal Stimulatory Effects of Graves’ Monoclonal and Serum Immunoglobulin G on Adenosine 3′,5′-Monophosphate Production in FRTL-5 Thyroid Cells: A Potential Clinical Assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

An improved radioreceptor assay for TSH receptor antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Protein-A purified human immunoglobulins: a comparison of thyroid stimulating and thyrotrophin receptor binding activities in thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

The assay for thyroid stimulating immunoglobulins using cultured human thyroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Functionality of Thyroid-Stimulating Antibodies Assessed by Cryopreserved Human Thyroid Cell Bioassay*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Thyrotropin-independent mutant clones from FRTL5 rat thyroid cells: hormonal control mechanisms in differentiated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Cloning the Fisher rat thyroid cell line (FRTL-5): variability in clonal growth and 3,'5'-cyclic adenosine monophosphate response to thyrotropin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

THYROID BINDING ANTIBODIES AND OTHER IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WITH GRAVES’OPHTHALMOPATHY: EFFECT OF TREATMENT WITH CYCLOPHOSPHAMIDE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Changes in thyroid functions in patients with euthyroid Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Immunological features of nonimmunogenic hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

The Prevalence of Thyroid-Stimulating Antibodies in Goitrous Disease Assessed by Cytochemical Section Bioassay*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Thyroid growth-blocking antibodies in primary myxoedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Detection and Properties of TSH-Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Hashimoto’s Thyroiditis*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Pregnancy-Associated Changes in the Thyroid-Stimulating Antibody of Graves’ Disease and the Relationship to Neonatal Hyperthyroidism*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

Prediction of relapse in hyperthyroid Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965533-5

10.1016/S0025-6196(12)65533-5

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference